<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ometendo</journal-id><journal-title-group><journal-title xml:lang="ru">Ожирение и метаболизм</journal-title><trans-title-group xml:lang="en"><trans-title>Obesity and metabolism</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2071-8713</issn><issn pub-type="epub">2306-5524</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/2071-8713-4838</article-id><article-id custom-type="elpub" pub-id-type="custom">ometendo-4838</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Уровни резистина, адипонектинаи инсулинорезистентности у пациентов с разнойстепенью нарушений углеводного обмена</article-title><trans-title-group xml:lang="en"><trans-title>Urovni rezistina, adiponektinai insulinorezistentnosti u patsientov s raznoystepen'yu narusheniy uglevodnogo obmena</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Skudaeva</surname><given-names>E S</given-names></name></name-alternatives><email xlink:type="simple">solomonova.el@yandex.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Pashentseva</surname><given-names>A V</given-names></name></name-alternatives><email xlink:type="simple">a-pashentseva@yandex.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Verbovoy</surname><given-names>A F</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib></contrib-group><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>15</day><month>09</month><year>2011</year></pub-date><volume>8</volume><issue>3</issue><issue-title>№3 (2011)</issue-title><fpage>57</fpage><lpage>60</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Skudaeva E.S., Pashentseva A.V., Verbovoy A.F., 2011</copyright-statement><copyright-year>2011</copyright-year><copyright-holder xml:lang="ru">Skudaeva E.S., Pashentseva A.V., Verbovoy A.F.</copyright-holder><copyright-holder xml:lang="en">Skudaeva E.S., Pashentseva A.V., Verbovoy A.F.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.omet-endojournals.ru/jour/article/view/4838">https://www.omet-endojournals.ru/jour/article/view/4838</self-uri><abstract><p>В основе патогенеза этого сахарного диабета 2 типа (СД2) лежат ожирение и инсулинорезистентность. Жировая
ткань является гормонально активной системой, которая вырабатывает адипонектин, резистин и другие адипокины. В статье представлены результаты исследования, проведенного с целью изучения роли адипонектина, резистина в развитии
инсулинорезистентности
у лиц с нарушенной толерантностью к глюкозе (НТГ) и СД2. Выявлено снижение уровня адипонек-
тина на фоне инсулинорезистентности у женщин и с НТГ, и с СД2, у мужчин только при СД2. Уровень резистина повышен
у пациентов и с НТГ, и с СД2.</p></abstract><trans-abstract xml:lang="en"><p>The basis of type 2 diabetes is obesity and insulin resistance. Fat tissue is hormonaly active system which produces adiponectin,
resistin and other adipokines. These substances participate in development of insulin resistance. The article presents the results of a study
conducted to examine the role of adiponectin, resistin in development of insulin resistance in patients with IGT and type 2 diabetes.
The reduction of adiponectin level and insulin resistance was found in women suffering from IGF or type 2 diabetes and in men with
only type 2 diabetes. Resistin levels were increased in the examined patients with IGT and with type 2 diabetes.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>сахарный диабет 2 типа</kwd><kwd>нарушенная толерантность к глюкозе</kwd><kwd>инсулинорезистентность</kwd><kwd>инсулин</kwd><kwd>адипонектин</kwd><kwd>резистин</kwd></kwd-group><kwd-group xml:lang="en"><kwd>diabetes mellitus type 2</kwd><kwd>impaired glucose tolerance</kwd><kwd>insulin resistance</kwd><kwd>insulin</kwd><kwd>adiponectin</kwd><kwd>resistin</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Метаболический синдром / Под ред. чл.-корр. РАМН г.Е. Ройтберга. - М.: МЕД-пресс-Информ, 2007. - 224 с.</mixed-citation><mixed-citation xml:lang="en">Метаболический синдром / Под ред. чл.-корр. РАМН г.Е. Ройтберга. - М.: МЕД-пресс-Информ, 2007. - 224 с.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Fernández-Real J.M., Botas-Cervero P., López-Bermano A., Casamitjana R., Funahashi T., Delgado E., Kihara S., Ricart W. Adiponectin is independently associated with glycosylated haemoglobin // Eur J Endocrinol. - 2004. - № 150 (2). - Р. 201-5.</mixed-citation><mixed-citation xml:lang="en">Fernández-Real J.M., Botas-Cervero P., López-Bermano A., Casamitjana R., Funahashi T., Delgado E., Kihara S., Ricart W. Adiponectin is independently associated with glycosylated haemoglobin // Eur J Endocrinol. - 2004. - № 150 (2). - Р. 201-5.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., Tataranni P.A. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia // J Clin Endocrinol Metab. - 2001. - № 86 (5). - Р. 1930-5.</mixed-citation><mixed-citation xml:lang="en">Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., Tataranni P.A. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia // J Clin Endocrinol Metab. - 2001. - № 86 (5). - Р. 1930-5.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Cnop M., Havel P.J., Utzschneider K.M., Carr D.B., Sinha M.K., Boyko E.J., Retzlaff B.M., Knopp R.H., Brunzell J.D., Kahn S.E. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex // Diabetologia. - 2003. - № 46 (4). - Р. 459-69.</mixed-citation><mixed-citation xml:lang="en">Cnop M., Havel P.J., Utzschneider K.M., Carr D.B., Sinha M.K., Boyko E.J., Retzlaff B.M., Knopp R.H., Brunzell J.D., Kahn S.E. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex // Diabetologia. - 2003. - № 46 (4). - Р. 459-69.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Hivert M.F., Sullivan L.M., Fox C.S., Nathan D.M., D'Agostino R.B. Sr., Wilson P.W., Meigs J.B. Associations of adiponectin, resistin, and tumor necrosis factoralpha with insulin resistance // J Clin Endocrinol Metab. - 2008. - № 93 (8). - Р. 3165-72. Epub 2008 May 20.</mixed-citation><mixed-citation xml:lang="en">Hivert M.F., Sullivan L.M., Fox C.S., Nathan D.M., D'Agostino R.B. Sr., Wilson P.W., Meigs J.B. Associations of adiponectin, resistin, and tumor necrosis factoralpha with insulin resistance // J Clin Endocrinol Metab. - 2008. - № 93 (8). - Р. 3165-72. Epub 2008 May 20.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Burnett M.S., Devaney J.M., Adenika R.J. Cross-Sectional Associations of Resistin, Coronary Heart Disease, and Insulin Resistance // J. Clin. Endocrinol. Metab. - 2006. - № 91 (1). - Р. 64-68.</mixed-citation><mixed-citation xml:lang="en">Burnett M.S., Devaney J.M., Adenika R.J. Cross-Sectional Associations of Resistin, Coronary Heart Disease, and Insulin Resistance // J. Clin. Endocrinol. Metab. - 2006. - № 91 (1). - Р. 64-68.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mojiminiyi O.A., Abdella N.A. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus // Scand J Clin Lab Invest. - 2007. - № 67 (2). - Р. 215-25.</mixed-citation><mixed-citation xml:lang="en">Mojiminiyi O.A., Abdella N.A. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus // Scand J Clin Lab Invest. - 2007. - № 67 (2). - Р. 215-25.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Farvid M.S., Ng T.W.C., Chan D.C., Barret P.H.R., Watts G.F. Associations of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidemia // Diabetes, obesity and metabolism. - 2005. - № 4. - P. 406-413.</mixed-citation><mixed-citation xml:lang="en">Farvid M.S., Ng T.W.C., Chan D.C., Barret P.H.R., Watts G.F. Associations of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidemia // Diabetes, obesity and metabolism. - 2005. - № 4. - P. 406-413.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Koebnick C., Wagner K., Garcia A.L., Gruendel S., Lahmann P.H. Increase in serum resistin during weight loss in overweight subjects is related to lipid metabolism // Int. J. Obesity. - 2006. - № 30 (7). - P. 1097-1103.</mixed-citation><mixed-citation xml:lang="en">Koebnick C., Wagner K., Garcia A.L., Gruendel S., Lahmann P.H. Increase in serum resistin during weight loss in overweight subjects is related to lipid metabolism // Int. J. Obesity. - 2006. - № 30 (7). - P. 1097-1103.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Diez J.J., Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease // Eur.J. of Endocrinology. - 2003. - Vol. 148. - P. 293-300.</mixed-citation><mixed-citation xml:lang="en">Diez J.J., Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease // Eur.J. of Endocrinology. - 2003. - Vol. 148. - P. 293-300.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang J.-L., Qin Y.W., Qiu J.-L., Zou D.-J. Serum resistin level in essential hypertension patients with different glucose tolerance // Diabet Med. - 2003. - № 20 (10).</mixed-citation><mixed-citation xml:lang="en">Zhang J.-L., Qin Y.W., Qiu J.-L., Zou D.-J. Serum resistin level in essential hypertension patients with different glucose tolerance // Diabet Med. - 2003. - № 20 (10).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
